Kazuo Miyazaki

Title: Kazuo Miyazaki: Innovator in Pharmaceutical Crystallization

Introduction

Kazuo Miyazaki is a notable inventor based in Yokkaichi, Japan. He has made significant contributions to the field of pharmaceutical crystallization, particularly in the production of nateglinide B-type crystals. His innovative methods have implications for the pharmaceutical industry, enhancing the efficiency of drug production.

Latest Patents

Miyazaki holds a patent for "Methods for producing nateglinide B-type crystals." This patent describes a method for producing B-type crystals of nateglinide that are substantially free of H-type crystals. The process involves drying solvated wet crystals of nateglinide at low temperatures until no solvent remains, followed by a crystal conversion. This method allows for the industrial-scale production of B-type crystals without the coexistence of other crystalline polymorphs.

Career Highlights

Kazuo Miyazaki has dedicated his career to advancing crystallization techniques in the pharmaceutical sector. His work at Ajinomoto Co., Ltd. has positioned him as a key figure in the development of efficient drug manufacturing processes. His innovative approach has not only improved production methods but also contributed to the overall quality of pharmaceutical products.

Collaborations

Miyazaki has collaborated with notable colleagues, including Makoto Maruo and Michito Sumikawa. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the field.

Conclusion

Kazuo Miyazaki's contributions to the field of pharmaceutical crystallization exemplify the impact of innovative thinking in drug production. His patented methods for producing nateglinide B-type crystals represent a significant advancement in the industry. Through his work, he continues to influence the future of pharmaceutical manufacturing.